BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 30273371)

  • 1. The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer.
    Gąsior-Perczak D; Pałyga I; Szymonek M; Kowalik A; Walczyk A; Kopczyński J; Lizis-Kolus K; Trybek T; Mikina E; Szyska-Skrobot D; Gadawska-Juszczyk K; Hurej S; Szczodry A; Słuszniak A; Słuszniak J; Mężyk R; Góźdź S; Kowalska A
    PLoS One; 2018; 13(10):e0204668. PubMed ID: 30273371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of body mass index on the clinicopathological features of 13,995 papillary thyroid tumors.
    Li CL; Dionigi G; Zhao YS; Liang N; Sun H
    J Endocrinol Invest; 2020 Sep; 43(9):1283-1299. PubMed ID: 32166701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth Editions.
    Tam S; Boonsripitayanon M; Amit M; Fellman BM; Li Y; Busaidy NL; Cabanillas ME; Dadu R; Sherman S; Waguespack SG; Williams MD; Goepfert RP; Gross ND; Perrier ND; Sturgis EM; Zafereo ME
    Thyroid; 2018 Oct; 28(10):1301-1310. PubMed ID: 30141373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poorly differentiated thyroid cancer in the context of the revised 2015 American Thyroid Association Guidelines and the Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System (eighth edition).
    Walczyk A; Kopczyński J; Gąsior-Perczak D; Pałyga I; Kowalik A; Chrapek M; Hejnold M; Góźdź S; Kowalska A
    Clin Endocrinol (Oxf); 2019 Aug; 91(2):331-339. PubMed ID: 30525210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer.
    Kim HJ; Kim NK; Choi JH; Sohn SY; Kim SW; Jin SM; Jang HW; Suh S; Min YK; Chung JH; Kim SW
    Clin Endocrinol (Oxf); 2013 Jan; 78(1):134-40. PubMed ID: 22812676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifocality Is not an Independent Prognostic Factor in Papillary Thyroid Cancer: A Propensity Score-Matching Analysis.
    Geron Y; Benbassat C; Shteinshneider M; Or K; Markus E; Hirsch D; Levy S; Ziv-Baran T; Muallem-Kalmovich L
    Thyroid; 2019 Apr; 29(4):513-522. PubMed ID: 30799769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH; Shen WT; Gosnell J; Duh QY
    Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
    Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
    Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using the American Thyroid Association Risk-Stratification System to Refine and Individualize the American Joint Committee on Cancer Eighth Edition Disease-Specific Survival Estimates in Differentiated Thyroid Cancer.
    Ghaznavi SA; Ganly I; Shaha AR; English C; Wills J; Tuttle RM
    Thyroid; 2018 Oct; 28(10):1293-1300. PubMed ID: 29897011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk for Thyroid Cancer Recurrence Is Higher in Men Than in Women Independent of Disease Stage at Presentation.
    Zahedi A; Bondaz L; Rajaraman M; Leslie WD; Jefford C; Young JE; Pathak KA; Bureau Y; Rachinsky I; Badreddine M; De Brabandere S; Fong H; Maniakas A; Van Uum S
    Thyroid; 2020 Jun; 30(6):871-877. PubMed ID: 31524071
    [No Abstract]   [Full Text] [Related]  

  • 12. Reassessment of Differentiated Thyroid Cancer Patients Using the Eighth TNM/AJCC Classification System: A Comparative Study.
    Shteinshnaider M; Muallem Kalmovich L; Koren S; Or K; Cantrell D; Benbassat C
    Thyroid; 2018 Feb; 28(2):201-209. PubMed ID: 29256827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of gross extrathyroidal extension into major neck structures on the prognosis of papillary thyroid carcinoma according to the American Joint Committee on Cancer eighth edition.
    Moritani S
    Endocr J; 2020 Sep; 67(9):941-948. PubMed ID: 32461538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association between body mass index and aggressiveness of papillary thyroid carcinoma].
    Faure EN; Soutelo MJ; Fritz MC; Martín A; Musri Y; Lutfi R
    Medicina (B Aires); 2018; 78(3):145-150. PubMed ID: 29940539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is body mass index relevant to prognosis of papillary thyroid carcinoma? A clinicopathological cohort study.
    Chung YS; Lee JH; Lee YD
    Surg Today; 2017 Apr; 47(4):506-512. PubMed ID: 27654453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of body mass index at diagnosis on outcome of thyroid cancer in children and adolescents.
    Zhang X; Jiang L; Liu L; Liu B
    Surgery; 2021 Jun; 169(6):1373-1378. PubMed ID: 33612290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incidence of papillary thyroid carcinoma and outcomes in operative patients according to their body mass indices.
    Trésallet C; Seman M; Tissier F; Buffet C; Lupinacci RM; Vuarnesson H; Leenhardt L; Menegaux F
    Surgery; 2014 Nov; 156(5):1145-52. PubMed ID: 24878452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Older patients with differentiated thyroid cancer exhibit more aggressive pathological characteristics than younger patients.
    Johar J; Britton H; Wiseman SM
    Can J Surg; 2020 Feb; 63(1):E69-E70. PubMed ID: 32031767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between body mass index and thyroid cancer pathology features and outcomes: a clinicopathological cohort study.
    Paes JE; Hua K; Nagy R; Kloos RT; Jarjoura D; Ringel MD
    J Clin Endocrinol Metab; 2010 Sep; 95(9):4244-50. PubMed ID: 20519347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between obesity and clinicopathological factors in patients with papillary thyroid cancer.
    Kim SH; Park HS; Kim KH; Yoo H; Chae BJ; Bae JS; Jung SS; Song BJ
    Surg Today; 2015 Jun; 45(6):723-9. PubMed ID: 25059345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.